Peptic Ulcer Global Market Report 2024 - By Demand, Share, Size, Trends, Outlook By 2033

The peptic ulcer market size has grown steadily in recent years. It will grow from $3.94 billion in 2023 to $4.1 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to increased prevalence of helicobacter pylori infection, rising use of nonsteroidal anti-inflammatory drugs (nsaids), changing lifestyles and dietary habits, awareness campaigns and educational initiatives, focus on stress management.

The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.69 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to emerging therapies and treatment modalities, increasing geriatric population, integration of precision medicine, preventive measures and health promotion, continued research and clinical trials. Major trends in the forecast period include digital health solutions, advancements in treatment modalitie, increasing prevalence of helicobacter pylori infection, integration of diagnostic imaging technologies, increasing use of combination therapies.

Market Overview -
A peptic ulcer is an open sore or raw area in the stomach lining or intestine. It is primarily caused by the erosion of the stomach's protective lining or the upper part of the small intestine (duodenum). The common peptic ulcer symptoms include upper abdominal pain or discomfort and acid reflux symptoms like heartburn, sometimes accompanied by nausea.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp

Obesity Fuels The Expansion Of The Peptic Ulcer Market
The growing prevalence of obesity is expected to propel the growth of the peptic ulcer market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat, typically resulting in an individual having a body mass index (BMI) of 30 or higher. Obesity can result from genetic, environmental, and lifestyle factors, such as a poor diet and a lack of physical activity. Obesity leads to the overproduction of stomach acid, weakens the stomach's protective mucosal lining, and contributes to developing peptic ulcers. Moreover, excess weight seems to promote inflammation in the gut, which can lead to the development of peptic ulcers. For instance, in March 2022, according to the World Obesity Atlas 2022 report, the estimated global number of people with obesity (Class I, II, and III) =30kg/m2 in 2020 was 764 million, expected to increase to 892 million by 2025. Therefore, the growing prevalence of obesity is driving the growth of the peptic ulcer market.

Competitive Landscape -
Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

Advancements In Peptic Ulcer Treatment With Dartisla ODT's FDA Approval
Companies operating in the peptic ulcer market are developing innovative products and solutions and getting them approved by federal agencies to gain a competitive edge. Drug development is crucial in managing and treating peptic ulcers. It aids in symptom management, healing, preventing complications, and treating the underlying problem. For instance, in December 2021, the U.S. Food and Drug Administration approved Dartisla ODT. This new drug for peptic ulcer treatment aids functions by lessening symptoms. It is the first medication authorized as a supplement for treating peptic ulcer disease is Dartisla ODT. Dartisla ODT is known to have anticholinergic properties, as every tablet has been incorporated with 1.7 mg of glycopyrrolate.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Key Segments -
The peptic ulcer market covered in this report is segmented -
1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-commerce

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model"

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.